A
Altimmune D
D
ALT
8.40000
USD
0.36
(4.48%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-5
Market Cap
596,995,988
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Altimmune
Sector: Healthcare
Industry: Biotechnology
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.